On Tuesday, Zai Lab Limited ADR (NASDAQ: ZLAB) was -5.07% drop from the session before settling in for the closing price of $30.95. A 52-week range for ZLAB has been $16.01 – $39.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 118.89% over the past five years. When this article was written, the company’s average yearly earnings per share was at 42.96%. With a float of $108.80 million, this company’s outstanding shares have now reached $109.84 million.
Let’s look at the performance matrix of the company that is accounted for 1869 employees. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zai Lab Limited ADR stocks. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 54.90%. The most recent insider transaction that took place on Apr 04 ’25, was worth 111,044. In this transaction an insider of this company sold 3,354 shares at a rate of $33.11, taking the stock ownership to the 67,345 shares. Before that another transaction happened on Apr 04 ’25, when Company’s Chief Legal Officer sold 1,874 for $33.11, making the entire transaction worth $62,044. This insider now owns 30,375 shares in total.
Zai Lab Limited ADR (ZLAB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 42.96% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
You can see what Zai Lab Limited ADR (ZLAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Zai Lab Limited ADR (NASDAQ: ZLAB) saw its 5-day average volume 0.9 million, a negative change from its year-to-date volume of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 6.28%. Additionally, its Average True Range was 1.90.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 34.86%, which indicates a significant increase from 16.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.65% in the past 14 days, which was lower than the 68.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.43, while its 200-day Moving Average is $26.90. Nevertheless, the first resistance level for the watch stands at $30.33 in the near term. At $31.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.85. If the price goes on to break the first support level at $28.81, it is likely to go to the next support level at $28.24. The third support level lies at $27.29 if the price breaches the second support level.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are 110,328K outstanding shares of the company, which has a market capitalization of 3.23 billion. As of now, sales total 398,990 K while income totals -257,100 K. Its latest quarter income was 109,070 K while its last quarter net income were -81,680 K.
